Alterity Therapeutics Limited
PRNAF
$0.0088
-$0.0013-12.87%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -13.05M | -12.83M | -12.56M | -10.33M | -8.15M |
| Total Depreciation and Amortization | 96.50K | 96.90K | 96.80K | 90.00K | 83.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 696.50K | 555.00K | 407.10K | 267.30K | 126.80K |
| Change in Net Operating Assets | 1.39M | 2.57M | 3.78M | 990.30K | -1.83M |
| Cash from Operations | -10.86M | -9.60M | -8.28M | -8.98M | -9.77M |
| Capital Expenditure | 0.00 | -1.90K | -3.80K | -4.60K | -5.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -9.70K | -19.70K |
| Cash from Investing | 0.00 | -1.90K | -3.80K | -14.30K | -25.10K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -23.80K | -17.10K | -10.40K | -48.70K | -87.00K |
| Issuance of Common Stock | 9.17M | 9.66M | 10.14M | 5.85M | 1.56M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -686.60K | -802.30K | -918.00K | -612.40K | -306.80K |
| Cash from Financing | 5.57M | 5.82M | 6.06M | 3.41M | 762.10K |
| Foreign Exchange rate Adjustments | 146.30K | 158.70K | 171.40K | 240.30K | 313.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.14M | -3.63M | -2.05M | -5.35M | -8.72M |
